MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 95058-81-4
Formula C9H11F2N3O4MW 263.2Research-use catalog entryCOA/SDS by request

Gemcitabine

CAS Number: 95058-81-4

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
10 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
500 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: SDUQYLNIPVEERB-QPPQHZFASA-NC9H11F2N3O4 | MW 263.2

Chemical Absolute Identifiers

CAS Number

95058-81-4

PubChem CID

60750

Molecular Formula

C9H11F2N3O4

Molecular Weight

263.2 g/mol

Exact Mass

263.071762

InChIKey

SDUQYLNIPVEERB-QPPQHZFASA-N

IUPAC Name

4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

SMILES String

C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F

Physical Properties

Appearance

Crystals from water, pH = 8.5

Melting Point

168.6 °C

pKa

3.6

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Gemcitabine (CAS 95058-81-4) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C9H11F2N3O4 and molecular weight 263. 20 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Equilibrative nucleoside transporter 1 (Homo sapiens) — 2 assays; Cytidine deaminase (Homo sapiens) — 6 assays; Deoxycytidine kinase (Homo sapiens) — 4 assays; 5-hydroxytryptamine receptor 1A (Homo sapiens) — 3 assays; Alpha-1A adrenergic receptor (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Equilibrative nucleoside transporter 1

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 6.72

Experimental evidence source: ChEMBL

Cytidine deaminase

Homo sapiens · SINGLE PROTEIN · 6 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Deoxycytidine kinase

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 3 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 1A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Alpha-1A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

PPE

Respiratory protection if needed

First Aid

  • Do not give anything to an unconscious person.
  • Rinse mouth with water.

Stability / Reactivity

  • Reactivity.
  • Carbon monoxide, carbon dioxide, hydrogen fluoride, nitrogen oxides.

Disposal

  • Waste product: Dispose of remaining and non-recyclable solutions to a licensed company.
  • Contact a professional agency with a waste disposal license to handle this substance.
Show additional safety reference fields

Fire Fighting

  • If necessary, wear a self-contained breathing apparatus for firefighting.

Accidental Release

  • Do not generate dust when collecting and disposing.
  • Sweep and shovel up.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Gemcitabine

Names & Synonyms

2'-Deoxy-2',2'-difluorocytidine2',2'-DifluorodeoxycytidinedFdCGemcitabinaGemcitabinum
Show all synonyms
DFdCyd4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one2',2'-difluoro-2'-deoxycytidine2'deoxy-2',2'-difluorocytidine4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-onegemicitabine4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-oneHydrochloride, Gemcitabine2'-deoxy-2'-difluorocytidine2' Deoxy 2' Difluorocytidine1-(2-oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose188011, LY2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate
External Identifiers
EC NUMBER: 619-100-6DSSTOX SUBSTANCE ID: DTXSID3040487CHEMBL ID: CHEMBL888CHEBI ID: CHEBI:175901UNII: B76N6SBZ8RDRUGBANK ID: DB00441HMDB ID: HMDB0014584KEGG ID: C07650KEGG ID: D02368METABOLOMICS WORKBENCH ID: 42796NCI THESAURUS CODE: C66876PHARMGKB ID: PA449748RXCUI: 12574WIKIDATA ID: Q414143
Experimental Spectrum References
UV Spectra
Literature & Patent References
DOI 10.1016/j.bmcl.2025.130096Applications of innovative synthetic strategies in anticancer drug discovery: The driving force of new chemical reactions.DOI 10.1016/j.ejmech.2025.117313Anti-tumor effects of artemisinin-based oligomers: From monomer to trimer as a novel drug-enhancing strategy.DOI 10.1016/j.ejmech.2025.117469Exploring the broad-spectrum activity of carbohydrate-based Iberin analogues: From anticancer effect to antioxidant properties.DOI 10.1021/acs.jmedchem.4c02380Discovery of the Clinical Candidate <b>YY2201</b> as a Highly Potent and Selective ATR Inhibitor.DOI 10.1021/acs.jmedchem.4c03069Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy.DOI 10.1021/acs.jmedchem.5c00056Substrate Specificity of the Organic Cation Transporters MATE1 and MATE2K and Functional Overlap with OCT1 and OCT2.PMID 39798856Applications of innovative synthetic strategies in anticancer drug discovery: The driving force of new chemical reactions.PMID 39914142Anti-tumor effects of artemisinin-based oligomers: From monomer to trimer as a novel drug-enhancing strategy.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Gemcitabine HydrochlorideCAS 122111-03-9
CytidineCAS 65-46-3
5'-Deoxy-5-fluorocytidineCAS 66335-38-4
((2R,3R)-3-(benzoyloxy)-4,4-difluoro-5-hydroxytetrahydrofuran-2-yl)methyl benzoateCAS 1173824-58-2
beta-D-RiboseCAS 36468-53-8

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 122111-03-9Gemcitabine HydrochlorideCAS 65-46-3CytidineCAS 100643-71-8DesloratadineCAS 106516-24-9SertindoleCAS 107724-20-9EplerenoneCAS 30516-87-1ZidovudineCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylate

RFQ questions for CAS 95058-81-4

What are the key identifiers for Gemcitabine (CAS 95058-81-4)?

Gemcitabine is identified by CAS 95058-81-4, with molecular formula C9H11F2N3O4, molecular weight 263.2, InChIKey SDUQYLNIPVEERB-QPPQHZFASA-N.

Does CAS 95058-81-4 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Equilibrative nucleoside transporter 1, Cytidine deaminase, Deoxycytidine kinase, 5-hydroxytryptamine receptor 1A, Alpha-1A adrenergic receptor. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 95058-81-4?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Gemcitabine?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 95058-81-4 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.